🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cat allergy is an increasingly prevalent condition, affecting 10-15% of pat...
Status
Completed
Location
Alpha Medical Research
Start Date
2009-03
Trial ID
NCT00867906
This study was designed to investigate the 1 year efficacy and safety of th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-06
Trial ID
NCT00929110
Treatments Being Tested
GSK159802 is a potent, inhaled, long acting selective beta-2-receptor agoni...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-08-24
Trial ID
NCT00364273
Treatments Being Tested
This study is designed to provide data about the 24 hours FEV1 profile, saf...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00557440
The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Status
Completed
Location
Colorado Allergy and Asthma Centers
Start Date
2015-12
Trial ID
NCT02624505
Treatments Being Tested
To compare the efficacy and safety profiles of Fluticasone Propionate 100 m...
Status
Unknown
Location
Multiple Locations
Start Date
2018-10
Trial ID
NCT03562923
Treatments Being Tested
This is a Phase 3, randomized, placebo-controlled, double-blind,double-dumm...
Status
Completed
Location
Teva Investigational Site 10851
Start Date
2013-12
Trial ID
NCT02031640
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab in children 6 to ...
Status
Completed
Location
Investigational Site Number 840031
Start Date
2017-04-21
Trial ID
NCT02948959
Treatments Being Tested
This study is examining how well a dry powder inhaler (DPI) of albuterol me...
Status
Completed
Location
Teva Clinical Study Site
Start Date
2010-02
Trial ID
NCT01058863
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab, compared with pl...
Status
Completed
Location
Investigational Site Number 840022
Start Date
2015-10-15
Trial ID
NCT02528214